Abstract

Background and aims: Quantifying placebo rates and the factors influencing them are essential to inform trial design. We provide a contemporary summary of clinical, endoscopic, histological and safety placebo rates in induction and maintenance clinical trials of ulcerative colitis, and identify factors influencing them.

Tags

Clinical Trials, Drug Therapy, Immunosuppressive Agents, Placebo, therapeutic use, Ulcerative Colitis

Read More